RxSight (RXST) Capital Expenditures (2020 - 2026)

RxSight's Capital Expenditures history runs 7 years deep, the most recent figure standing at $759000.0 for Q1 2026.

• Quarterly Capital Expenditures rose 272.06% year-over-year to $759000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $976000.0 (down 73.46% YoY) and the FY2025 annual result came in at $421000.0, down 92.26% from the prior year.
• Capital Expenditures was $759000.0 for Q1 2026 at RxSight, up from $286000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.8 million in Q3 2023 and bottomed at -$2.0 million in Q3 2025.
• A 5-year average of $690176.5 and a median of $759000.0 in 2026 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 1155.07% — and 2024, when it soared 922.15%.
• RxSight's Capital Expenditures stood at -$1.7 million in 2022, then jumped by 191.86% to $1.6 million in 2023, then slumped by 46.76% to $847000.0 in 2024, then plunged by 66.23% to $286000.0 in 2025, then soared by 165.38% to $759000.0 in 2026.
• Business Quant data shows RXST's Capital Expenditures at $759000.0 in Q1 2026, $286000.0 in Q4 2025, and -$2.0 million in Q3 2025.